Filed
May 8, 2024
Status Updated
Oct 10, 2024
Parties
2
Timeline Entries
23
Opposer
Mylan, Inc.
Counsel: CECILIA R. DICKSON
PITTSBURGH, PA, US
MY EPIPLAN
SN 85927539
Reg 4569544
EPIPEN
SN 85927541
Reg 4618280
EPIPEN
SN 73183957
Reg 1124454
EPIPEN4SCHOOLS
SN 85774449
Reg 4338825
EPIPEN JR
SN 85037357
Reg 3969162
EPILOCKER
SN 86193762
Reg 5095809
EPIPEN EPIPEN JR (EPINEPHRINE INJECTION) AUTO-INJECTORS 0.3/0.15 MG
SN 87006374
Reg 5131974
EPIPEN JR. 2-PAK
SN 76286512
Reg 2576013
EPIPEN
SN 73666943
Reg 1479294
EPIPEN (EPINEPHRINE INJECTION) AUTO-INJECTORS 0.3 MG EPIPEN JR (EPINEPHRINE INJECTION) AUTO-INJECTORS 0.15 MG
SN 87006376
Reg 5131975
EPIPEN (EPINEPHRINE INJECTION) AUTO-INJECTORS 0.3MG EPIPEN JR (EPINEPHRINE INJECTION) AUTO-INJECTORS 0.15MG
SN 87027849
Reg 5136005
MY EPIPEN
SN 87059734
Reg 5091238
EPIPEN 2-PAK
SN 76286513
Reg 2576014
Applicant
Belhaven Biopharma, Inc.
Counsel: BRENDAN J. HUGHES
WASHINGTON, DC, US
NASDEPI
SN 97826905
Prosecution History
| Date | Entry |
|---|---|
| Mar 12, 2026 | D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS |
| Nov 29, 2025 | REQ FOR PROG ON SETTL - SUSPENDED |
| Nov 21, 2025 | D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS |
| Aug 18, 2025 | REQ FOR PROG ON SETTL - SUSPENDED |
| Aug 18, 2025 | D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS |
| Jun 3, 2025 | REQ FOR PROG ON SETTL - SUSPENDED |
| Jun 2, 2025 | D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS |
| Mar 5, 2025 | SUSPENDED |
| Mar 5, 2025 | D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS |
| Jan 6, 2025 | SUSPENDED |
| Jan 6, 2025 | D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS |
| Oct 10, 2024 | SUSPENDED |
| Oct 10, 2024 | D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS |
| Aug 7, 2024 | EXTENSION OF TIME GRANTED |
| Aug 7, 2024 | D MOT FOR EXT W/ CONSENT |
| Jul 8, 2024 | EXTENSION OF TIME GRANTED |
| Jul 8, 2024 | D MOT FOR EXT W/ CONSENT |
| Jul 2, 2024 | D CHANGE OF CORRESP ADDRESS |
| Jun 11, 2024 | EXTENSION OF TIME GRANTED |
| Jun 11, 2024 | D MOT FOR EXT W/ CONSENT |
| May 8, 2024 | FILED AND FEE |
| May 8, 2024 | INSTITUTED |
| May 8, 2024 | NOTICE AND TRIAL DATES SENT; ANSWER DUE: |